3.15
0.05 (1.61%)
| 前收盘价格 | 3.10 |
| 收盘价格 | 3.16 |
| 成交量 | 229,641 |
| 平均成交量 (3个月) | 171,798 |
| 市值 | 12,616,475 |
| 52周波幅 | |
| 利润日期 | 9 Aug 2023 - 14 Aug 2023 |
| 营业利益率 (TTM) | -2,073.29% |
| 稀释每股收益 (EPS TTM) | -1.43 |
| 季度收入增长率 (YOY) | 2,170.70% |
| 总债务/股东权益 (D/E MRQ) | 121.86% |
| 流动比率 (MRQ) | 0.760 |
| 营业现金流 (OCF TTM) | -9.30 M |
| 杠杆自由现金流 (LFCF TTM) | -4.11 M |
| 资产报酬率 (ROA TTM) | -73.20% |
| 股东权益报酬率 (ROE TTM) | -490.37% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 混合的 | |
| 股票 | Predictive Oncology Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.6 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.0 |
| 相对估值 | NA |
| 财务健康 | -4.0 |
| 宏观环境 | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | 0.33 |
|
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Value |
| 内部持股比例 | 1.27% |
| 机构持股比例 | 2.07% |
该时间范围内无数据。
该时间范围内无数据。
投资组合